Search Results - "Brechelmacher, S"
-
1
Endothelin-1 genetic polymorphism as predictive marker for bevacizumab in metastatic breast cancer
Published in The pharmacogenomics journal (01-07-2017)“…Biomarkers for bevacizumab efficacy in metastatic breast cancer (MBC) are of urgent need. The genetic variability of genes involved in angiogenesis could…”
Get full text
Journal Article -
2
Abstract P1-08-32: Endothelin-1 genetic polymorphism as predictive marker for bevacizumab in metastatic breast cancer
Published in Cancer research (Chicago, Ill.) (15-12-2013)“…Background: Biomarkers predicting response or toxicity of bevacizumab containing therapy in breast cancer are of urgent need. The genetic variability of VEGF,…”
Get full text
Journal Article